Another study, published in The Lancet, found that body weight and body composition were maintained one year after the termination of GLP-1 medications through the use of supervised exercise, in contrast to weight regain after the termination of treatment with obesity pharmacotherapy alone
Understanding GLP-1 Drugs and Their Severe Side Effects Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications that have revolutionized the treatment of Type 2 diabetes and obesity
Semaglutide (used in GLP-1 medications like Ozempic and Wegovy) is a peptide drug, and tesamorelin is an FDA-approved synthetic growth hormone-releasing factor analogue
Precautions References In a randomized, single-blind, placebo-controlled trial including 150 obese participants, individuals received either 16g per day of native inulin or maltodextrin (placebo) along with dietary advice focused on consuming either inulin-rich or inulin-poor vegetables
You may upload your previous lab results into your portal or submit it to: [email protected] where someone from our team will upload it to your chart for your provider to review before your initial visit
A standard U-100 insulin syringe has 100 units per 1mL